Developer docs
API playgroundTry for free, no card

Search company profiles

Fellow Health

Full company profile

uuid0000d2q

Namestring
Fellow Health
Legal namestring
Fellow Health, Inc.
Websiteurl
meetfellow.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Fellow Health, Inc. (doing business as Fellow) operates a mail-in, clinical-grade andrology diagnostics platform headquartered in San Francisco, California, with laboratory operations referenced in San Leandro, California. The company's core offering is an at-home semen analysis kit that patients collect and ship to Fellow's CLIA-certified, COLA-accredited lab (CLIA #05D2177822; COLA #31245), where samples are processed using a proprietary algorithm that converts structured semen data into clinic-equivalent reports delivered in under two business days. Fellow has expanded its product line to include a dedicated post-vasectomy confirmation test and a semen analysis bundled with cryopreservation and tissue bank storage, supported by a tissue bank license and a newly obtained New York State high-complexity clinical laboratory permit (October 2025).

The company serves both consumers directly and, primarily, clinicians through a B2B2C distribution model, reporting embedding in 3,000+ fertility and urology practices and processing 400+ patient samples per day, with 200,000+ cumulative reports delivered. Revenue mechanics combine direct-to-consumer kit sales (typical mail-in andrology pricing in the low-hundreds range, higher for cryopreservation bundles) with clinic-channel prescription volume. Stripe is integrated for payment processing across both channels. Clinical credibility is supported by peer-reviewed validation in Fertility and Sterility (Samplaski et al., 2021) and reported operational metrics including 93% patient satisfaction and 86% post-vasectomy testing compliance.

Fellow has raised approximately $48M in total funding, most recently a $24M Series B in July 2025 led by 5AM Ventures with participation from The Forest Road Company; earlier capital came from 5AM Ventures, Genoa Ventures, Human Capital, LabCorp Venture Fund, and MANTIS Venture Capital. Leadership includes CEO Brian Hogan and independent Chairman Paul Kappelman, former CEO of Ovation Fertility. The Series B is explicitly aimed at scaling commercial reach and reaching profitability by 2026, with management targeting 40%+ growth in the fertility segment. Certain kit offerings remain unavailable in Hawaii, Alaska, and previously in New York, though the latter restriction has been addressed by the recent high-complexity permit.

Short descriptiontext

Fellow Health is a San Francisco-based, CLIA-certified diagnostics company offering mail-in clinical-grade semen analysis and cryopreservation kits to patients, distributed primarily through 3,000+ fertility and urology practices across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
mail-in semen analysis, male fertility testing, clinical diagnostics lab, sperm cryopreservation, post-vasectomy testing
Industry4 codes
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Clinical Fertility Diagnostics
Social media profiles3 records
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Fellow Health operates a CLIA-certified, COLA-accredited clinical diagnostics laboratory that provides peer-reviewed, mail-in semen analysis, post-vasectomy testing, and sperm cryopreservation services to patients at home and to urology, fertility, and OB/GYN clinical practices. Consumers purchase test kits directly through the Fellow website; samples are mailed to the Fellow lab where a proprietary algorithm processes structured specimen data and returns clinic-equivalent results in less than 2 business days.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Vasectomy Test
CategoryPost-vasectomy diagnostics
Description

Mail-in post-vasectomy semen analysis test kit that allows vasectomy patients to confirm procedural success from home; results are returned to the ordering clinic in less than 2 business days from sample receipt and is associated with an 86% compliance rate versus typical in-clinic post-vasectomy testing.

2Semen Analysis
CategoryMale fertility diagnostics
Description

Mail-in, peer-reviewed clinical semen analysis test kit for men evaluating fertility; sample is collected at home, mailed to Fellow's CLIA-certified lab, and processed with a proprietary algorithm to produce clinic-equivalent metrics (count, motility, progressive motility, morphology, volume) returned in less than 2 business days.

3Semen Analysis + Cryopreservation
CategoryFertility diagnostics and cryopreservation
Description

Combined mail-in semen analysis and elective sperm cryopreservation offering that lets men complete a full fertility analysis and store their sperm for future fertility treatments with a partner, under Fellow's tissue bank license.

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Stripe serves as Fellow Health's payment processing vendor, enabling secure online transactions for consumer test kit purchases (semen analysis, vasectomy test, and cryopreservation subscriptions) directly on the Fellow website.

Strategic tierMinorTypeOthers
Description

Morgan Stanley Capital Partners is connected to Fellow Health through Paul Kappelman, who serves as Senior Independent Operating Advisor to the company.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Quest Diagnostics is the other major U.S. clinical reference laboratory offering reproductive/fertility testing. It is a broad incumbent with nationwide logistics infrastructure that could plausibly add a mail-in male-fertility product.

2Dadi
TypeDirect peer
Description

Dadi offers at-home male fertility testing and sperm storage via mail-in kits. It is the most directly comparable consumer-facing male-fertility mail-in competitor, with overlapping products (semen analysis + cryopreservation) and a similar DTC distribution model.

TypeDirect peer
Description

Legacy provides at-home sperm testing and cryopreservation with mail-in kits. It directly competes for the same male-fertility consumer and offers overlapping cryopreservation/storage subscriptions that rival Fellow's storage product.

TypeDirect peer
Description

YO sells FDA-cleared smartphone-based at-home sperm analysis kits. It competes in the same consumer male-fertility self-test category as Fellow, though via a connected device rather than a mail-in lab workflow.

TypeDirect peer
Description

Trak is an at-home male-fertility testing product with a mail-in lab component for confirmatory analysis. It targets the same male-factor infertility and post-vasectomy testing use cases that Fellow serves.

TypeBroad incumbent
Description

Labcorp is one of the largest U.S. clinical laboratory networks with established andrology/fertility testing services and even participated in a prior Fellow financing round. It is a broad incumbent with overlapping diagnostic capabilities and significantly greater scale.

7Ro
TypeEmerging player
Description

Ro operates a direct-to-patient men's health and fertility platform (Ro Fertility) offering at-home semen analysis and treatment. It competes for the same male-fertility consumer with deeper digital-marketing reach and a broader men's health portfolio.

TypeEmerging player
Description

Progyny is a leading employer-sponsored fertility benefits platform. It is comparable as a channel/buyer for Fellow's employer-sponsored fertility expansion strategy and shapes covered-product design for male-fertility testing.

TypeEmerging player
Description

Carrot is a fast-growing fertility and family-forming benefits platform serving employers. It is comparable as a distribution channel for Fellow's employer-sponsored fertility push and could integrate mail-in male-fertility testing into its covered services.

TypeRegional player
Description

Ovation Fertility is one of the largest U.S. fertility-clinic networks, with whom Fellow's new Independent Chairman Paul Kappelman was previously CEO. It is a regional/network player in reproductive medicine that interfaces with mail-in labs like Fellow for diagnostic referrals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fellow Health

Clinical Fertility Diagnosticsmeetfellow.com

Fellow Health is a San Francisco-based, CLIA-certified diagnostics company offering mail-in clinical-grade semen analysis and cryopreservation kits to patients, distributed primarily through 3,000+ fertility and urology practices across the United States.

What Fellow Health does

Fellow Health, Inc. (doing business as Fellow) operates a mail-in, clinical-grade andrology diagnostics platform headquartered in San Francisco, California, with laboratory operations referenced in San Leandro, California. The company's core offering is an at-home semen analysis kit that patients collect and ship to Fellow's CLIA-certified, COLA-accredited lab (CLIA #05D2177822; COLA #31245), where samples are processed using a proprietary algorithm that converts structured semen data into clinic-equivalent reports delivered in under two business days. Fellow has expanded its product line to include a dedicated post-vasectomy confirmation test and a semen analysis bundled with cryopreservation and tissue bank storage, supported by a tissue bank license and a newly obtained New York State high-complexity clinical laboratory permit (October 2025).

The company serves both consumers directly and, primarily, clinicians through a B2B2C distribution model, reporting embedding in 3,000+ fertility and urology practices and processing 400+ patient samples per day, with 200,000+ cumulative reports delivered. Revenue mechanics combine direct-to-consumer kit sales (typical mail-in andrology pricing in the low-hundreds range, higher for cryopreservation bundles) with clinic-channel prescription volume. Stripe is integrated for payment processing across both channels. Clinical credibility is supported by peer-reviewed validation in Fertility and Sterility (Samplaski et al., 2021) and reported operational metrics including 93% patient satisfaction and 86% post-vasectomy testing compliance.

Fellow has raised approximately $48M in total funding, most recently a $24M Series B in July 2025 led by 5AM Ventures with participation from The Forest Road Company; earlier capital came from 5AM Ventures, Genoa Ventures, Human Capital, LabCorp Venture Fund, and MANTIS Venture Capital. Leadership includes CEO Brian Hogan and independent Chairman Paul Kappelman, former CEO of Ovation Fertility. The Series B is explicitly aimed at scaling commercial reach and reaching profitability by 2026, with management targeting 40%+ growth in the fertility segment. Certain kit offerings remain unavailable in Hawaii, Alaska, and previously in New York, though the latter restriction has been addressed by the recent high-complexity permit.

Fellow Health firmographics

Firmographics
Name
Fellow Health
Legal name
Fellow Health, Inc.
Website
https://meetfellow.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Fellow Health is a San Francisco-based, CLIA-certified diagnostics company offering mail-in clinical-grade semen analysis and cryopreservation kits to patients, distributed primarily through 3,000+ fertility and urology practices across the United States.
Ownership category
akta.pro rank

Fellow Health industry classification

Industry
Product category
Clinical Fertility Diagnostics
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • Mail-in semen analysis
  • Male fertility testing
  • Clinical diagnostics lab
  • Sperm cryopreservation
  • Post-vasectomy testing

Where Fellow Health is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Fellow Health business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Fellow Health product offering

Product offering

Core offering

Fellow Health operates a CLIA-certified, COLA-accredited clinical diagnostics laboratory that provides peer-reviewed, mail-in semen analysis, post-vasectomy testing, and sperm cryopreservation services to patients at home and to urology, fertility, and OB/GYN clinical practices. Consumers purchase test kits directly through the Fellow website; samples are mailed to the Fellow lab where a proprietary algorithm processes structured specimen data and returns clinic-equivalent results in less than 2 business days.

Differentiator

Problem solved

Functional benefit

Products and services

  • Vasectomy Test Mail-in post-vasectomy semen analysis test kit that allows vasectomy patients to confirm procedural success from home; results are returned to the ordering clinic in less than 2 business days from sample receipt and is associated with an 86% compliance rate versus typical in-clinic post-vasectomy testing.
  • Semen Analysis Mail-in, peer-reviewed clinical semen analysis test kit for men evaluating fertility; sample is collected at home, mailed to Fellow's CLIA-certified lab, and processed with a proprietary algorithm to produce clinic-equivalent metrics (count, motility, progressive motility, morphology, volume) returned in less than 2 business days.
  • Semen Analysis + Cryopreservation Combined mail-in semen analysis and elective sperm cryopreservation offering that lets men complete a full fertility analysis and store their sperm for future fertility treatments with a partner, under Fellow's tissue bank license.

Companies that use Fellow Health

Customer profile

Ideal customer profiles2 records

Fellow Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability1 record

Fellow Health partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • StripecoreTechnology or IntegrationStripe serves as Fellow Health's payment processing vendor, enabling secure online transactions for consumer test kit purchases (semen analysis, vasectomy test, and cryopreservation subscriptions) directly on the Fellow website.
  • Morgan Stanley Capital PartnersminorOthersMorgan Stanley Capital Partners is connected to Fellow Health through Paul Kappelman, who serves as Senior Independent Operating Advisor to the company.

Recent moves7 records

Expansion highlights5 records

Fellow Health competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is the other major U.S. clinical reference laboratory offering reproductive/fertility testing. It is a broad incumbent with nationwide logistics infrastructure that could plausibly add a mail-in male-fertility product.
  • Labcorp: Labcorp is one of the largest U.S. clinical laboratory networks with established andrology/fertility testing services and even participated in a prior Fellow financing round. It is a broad incumbent with overlapping diagnostic capabilities and significantly greater scale.

Direct peers

  • Dadi: Dadi offers at-home male fertility testing and sperm storage via mail-in kits. It is the most directly comparable consumer-facing male-fertility mail-in competitor, with overlapping products (semen analysis + cryopreservation) and a similar DTC distribution model.
  • Legacy: Legacy provides at-home sperm testing and cryopreservation with mail-in kits. It directly competes for the same male-fertility consumer and offers overlapping cryopreservation/storage subscriptions that rival Fellow's storage product.
  • YO Home Sperm Test (Medical Electronic Systems): YO sells FDA-cleared smartphone-based at-home sperm analysis kits. It competes in the same consumer male-fertility self-test category as Fellow, though via a connected device rather than a mail-in lab workflow.
  • Trak (Sandstone Diagnostics): Trak is an at-home male-fertility testing product with a mail-in lab component for confirmatory analysis. It targets the same male-factor infertility and post-vasectomy testing use cases that Fellow serves.

Emerging players

  • Ro: Ro operates a direct-to-patient men's health and fertility platform (Ro Fertility) offering at-home semen analysis and treatment. It competes for the same male-fertility consumer with deeper digital-marketing reach and a broader men's health portfolio.
  • Progyny: Progyny is a leading employer-sponsored fertility benefits platform. It is comparable as a channel/buyer for Fellow's employer-sponsored fertility expansion strategy and shapes covered-product design for male-fertility testing.
  • Carrot Fertility: Carrot is a fast-growing fertility and family-forming benefits platform serving employers. It is comparable as a distribution channel for Fellow's employer-sponsored fertility push and could integrate mail-in male-fertility testing into its covered services.

Regional players

  • Ovation Fertility: Ovation Fertility is one of the largest U.S. fertility-clinic networks, with whom Fellow's new Independent Chairman Paul Kappelman was previously CEO. It is a regional/network player in reproductive medicine that interfaces with mail-in labs like Fellow for diagnostic referrals.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Fellow Health social profiles

Digital presence

Fellow Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fellow Health leadership team

Management profile

Number of profiles

Profiles2 records

Fellow Health funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fellow Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fellow Health

What does Fellow Health do?

Fellow Health operates a CLIA-certified, COLA-accredited clinical diagnostics laboratory that provides peer-reviewed, mail-in semen analysis, post-vasectomy testing, and sperm cryopreservation services to patients at home and to urology, fertility, and OB/GYN clinical practices. Consumers purchase test kits directly through the Fellow website; samples are mailed to the Fellow lab where a proprietary algorithm processes structured specimen data and returns clinic-equivalent results in less than 2 business days.

Is Fellow Health a public or private company?

Fellow Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Fellow Health founded?

Fellow Health was founded in 2018. It employs 51 to 100 people.

Where is Fellow Health based?

Fellow Health is headquartered in San Francisco, United States, in the North America region.

Who are Fellow Health's main competitors?

Broad incumbents on record are Quest Diagnostics and Labcorp. Direct peers are Dadi, Legacy, YO Home Sperm Test (Medical Electronic Systems) and Trak (Sandstone Diagnostics). Emerging players are Ro, Progyny and Carrot Fertility. Ovation Fertility is listed as a regional player.

Does Fellow Health have an API?

No public API is recorded for Fellow Health.

What industry is Fellow Health in?

Fellow Health's product category is Clinical Fertility Diagnostics. Its primary akta.pro industry code is HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits), with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogFellow Health to Present Nine Studies at the ASRM 2026 Scientific Congress & ExpoFellow Health will present nine studies at the ASRM 2026 Scientific Congress & Expo in Baltimore, October 24–28. The studies draw on data from its mail-in semen analysis platform, which processes over 450 patient samples daily and partners with more than 3,000 fertility and urology practices.Business Wire BlogFellow Health Expands Mail-In Semen Analysis and Clinic Partnerships Across New YorkFellow Health expanded its mail-in semen analysis to fertility and urology practices statewide in New York, following conditional approval earlier this month. The test is available to providers immediately, with full state approval pending. The company partners with over 3,000 practices and processes 450 samples daily.Business Wire BlogFellow Health to Present Five Studies at the American Urological Association 2026 Annual MeetingFellow Health will present five studies at the AUA 2026 Annual Meeting in Washington, D.C., May 15–18, 2026, using its mail-in semen analysis platform. One study on 25,000 US men linking poor metabolic health to lower semen quality and higher IVF rates was selected for the AUA press release. The studies draw on over 3,000 fertility and urology practices.Business Wire BlogFellow Health Appoints Industry Executive Paul Kappelman as Independent Chairman of the BoardFellow Health appointed industry executive Paul Kappelman as Independent Chairman of the Board, bringing over 30 years of healthcare leadership experience including prior tenure as CEO of Ovation Fertility. Kappelman will support the company's next phase of growth as it expands its network of more than 3,000 fertility and urology practices. He currently serves as a Senior Independent Operating Advisor to Morgan Stanley Capital Partners, where he advises healthcare management teams on growth strategy and execution.MeetfellowFellow Health Closes $24M Series B for Male Fertility TestsFellow Health announced the closing of a $24 million Series B financing round aimed at expanding its male reproductive health testing services. The funds will support growth in mail-in semen analysis and broader market offerings, including new segments such as employer-sponsored benefits.MeetfellowFellow Health Closes a $24 Million Series B Financing to Expand its Male Reproductive Test Offerings - FellowFellow Health has closed a $24 million Series B financing round led by 5AM Ventures, with new participation from The Forest Road Company, bringing total capital raised to $48 million across all funding rounds. The company, which provides mail-in semen analysis services for fertility and post-vasectomy testing, will use the funds to scale its clinical partner network and expand into employer-sponsored fertility benefits, targeting 40% year-over-year revenue growth with a path to profitability in its fertility segment by 2026. Bill Burkoth of Forest Road will join Fellow Health's Board of Directors as part of the financing agreement.BenzingaFrom Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive HealthFellow Health raised $24 million in a Series B funding round led by 5AM Ventures, with Forest Road participating for the first time, bringing its total funding to $48 million. The San Leandro-based startup, which provides mail-in semen analysis services for male fertility and post-vasectomy testing, has delivered over 50,000 test results this year and is on track for 40% year-over-year revenue growth with a path to profitability in its fertility segment by 2026. The company plans to use the capital to expand into employer-sponsored fertility benefits and deepen its network of over 2,500 fertility and urology providers nationwide.YahooFrom Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive HealthFellow Health raised $24 million in a Series B round, bringing its total funding to $48 million. The San Leandro startup will use the capital to expand its mail-in semen analysis services and deepen its footprint in employer-sponsored fertility benefits. It has delivered over 50,000 test results this year.HLTHFellow Health Raises $24M To Expand Reproductive Testing ServicesFellow Health, a male reproductive health company, has raised $24 million in a Series B funding round led by 5AM Ventures with participation from The Forest Road Company, bringing its total capital raised to $48 million. The company operates a CLIA-certified laboratory offering mail-in semen analysis, vasectomy tests, and cryopreservation services, processing over 400 patient samples daily through partnerships with more than 1,800 clinical practices. Fellow Health plans to use the funding to expand its mail-in testing services and grow its clinical partner network, targeting over 40% year-over-year revenue growth and profitability in its fertility segment by 2026.Pulse 2.0Fellow Health: $24 Million Series B Raised For Expanding Male Reproductive Test OfferingsFellow Health closed a $24 million Series B led by 5AM Ventures, bringing total funding to $48 million. The investment will expand its at-home semen analysis services and enter the employer-sponsored fertility benefits market. The company targets over 40% year-over-year revenue growth and profitability in its fertility segment by 2026.